Market Place
Sourcing Support
PhRMA, Novartis Weigh In On FDA`s 3-Year Exclusivity Guidance
18 May 2026 //
RAPS
Psmaddition Data Reveals 58% Lower PSA Progression Risk
17 May 2026 //
GLOBENEWSWIRE
Novartis Sharpening India Strategy As A Pure-Play Innovator
14 May 2026 //
ECONOMICTIMES
Novartis expands India role in global drug development
11 May 2026 //
ECONOMICTIMES
Novartis to Exit Oral Drug Factory in Germany
08 May 2026 //
FIERCE PHARMA
Novartis Breaks Ground on Texas Radioligand Therapy Site
07 May 2026 //
GLOBENEWSWIRE
Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3
05 May 2026 //
FIERCE BIOTECH
Novartis Gets Health Canada Nod For Fabhalta In Adult C3G
02 May 2026 //
FIRSTWORD PHARMA
Novartis Reveals North Carolina Factory In $23B US Expansion
30 Apr 2026 //
ENDPOINTS
Lilly Inks Deals; Regeneron Secures Historic Q1 Win
29 Apr 2026 //
BIOSPACE
Novartis, PTC Advance Huntington`s Drug to Phase 3
29 Apr 2026 //
BIOSPACE
PTC Therapeutics To Share PIVOT-HD Study Long-Term Results
28 Apr 2026 //
PR NEWSWIRE
Novartis Posts Strong Q1 Growth, Reaffirms 2026 Guidance
28 Apr 2026 //
GLOBENEWSWIRE
Novartis CEO Concerned About Germany`s €60B Healthcare Spending
28 Apr 2026 //
ENDPOINTS
Argo Biopharma Doses First Patient in BW-50218 Phase 1 Trial
28 Apr 2026 //
PR NEWSWIRE
Novartis Cuts Hit New Jersey Again, Affecting 60 Employees
28 Apr 2026 //
BIOSPACE
Novartis Reports Earnings Miss Due To Generic Competition
28 Apr 2026 //
REUTERS
Novartis Highlights First Quarter Earnings Call
28 Apr 2026 //
FIRSTWORD PHARMA
EU Approves Novartis` Rhapsido as First Oral Therapy for CSU
27 Apr 2026 //
GLOBENEWSWIRE
Novartis` Coartem Baby Granted WHO Prequalification
24 Apr 2026 //
GLOBENEWSWIRE
Novartis Gets CHMP Nod For Itvisma In SMA
24 Apr 2026 //
GLOBENEWSWIRE
Novartis’s Rhapsido Receives Approval in Europe
23 Apr 2026 //
EMA
NCCN Honors Initiatives Advancing Leukemia CML Care
23 Apr 2026 //
PR NEWSWIRE
Novartis` Lutathera Radioligand Therapy Faces Generic Rivals
23 Apr 2026 //
ENDPOINTS
Novartis Narrows Anticoagulant`s Focus After Losing To Eliquis
22 Apr 2026 //
FIERCE BIOTECH
Novartis cuts two Programs in Cancer-Related Blood Clots
20 Apr 2026 //
ENDPOINTS
Novartis CEO Vas Narasimhan joins Anthropic board
20 Apr 2026 //
INDPHARMAPOST
NIPER Mohali And Novartis Partner To Enhance R&D Innovation
16 Apr 2026 //
INDPHARMAPOST
Novartis CEO Vas Narasimhan joins Anthropic`s board
16 Apr 2026 //
FIERCE PHARMA
Novartis Pumps Up Heart Disease, Cancer Community Health Plan
10 Apr 2026 //
FIERCE PHARMA
Novartis To Cut 114 More Jobs At New Jersey HQ
10 Apr 2026 //
FIERCE PHARMA
Novartis Expands Global Health Programs For Heart Disease
09 Apr 2026 //
GLOBENEWSWIRE
Biontech To Turn Out The Lights At Singapore Vaccine Facility
02 Apr 2026 //
FIERCE PHARMA
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%
29 Mar 2026 //
GLOBENEWSWIRE
Novartis to buy based biotech firm Excellergy for up to $2 bn
27 Mar 2026 //
REUTERS
Novartis Sued Over Third-Party Data Sharing From Branded Sites
25 Mar 2026 //
FIERCE PHARMA
Novartis Pledges $480M for China Expansion Following Lilly and AZ
24 Mar 2026 //
BIOSPACE
Novartis Shares Skin Relief Data at AAD 2026
23 Mar 2026 //
GLOBENEWSWIRE
Novartis Pledges Nearly $480M To Bolster China Production, R&D
23 Mar 2026 //
WEIXIN
Novartis to Buy Experimental Breast Cancer Drug in up to $3B
23 Mar 2026 //
REUTERS
Delhi HC Rebukes Patent Office For Delay In Breast Cancer Drug
18 Mar 2026 //
ECONOMICTIMES
Novartis` Cosentyx Gets FDA Approval for Moderate-to-Severe HS
14 Mar 2026 //
GLOBENEWSWIRE
Novartis Shareholders Approve Board Resolutions At AGM 2026
06 Mar 2026 //
GLOBENEWSWIRE
How Jeff Legos Builds Pfizer`s Oncology Future
04 Mar 2026 //
FIERCE BIOTECH
Novartis Completes Acquisition of Avidity Biosciences
27 Feb 2026 //
GLOBENEWSWIRE
Atrium Arises From Avidity Buyout With $270M, Preclinical Assets
27 Feb 2026 //
FIERCE BIOTECH
Novartis Receives Positive CHMP Opinion for Remibrutinib in CSU
27 Feb 2026 //
GLOBENEWSWIRE
Novartis Picks Texas City for 5th U.S. Radiopharm Facility
25 Feb 2026 //
BIOSPACE
Novartis Settles Lawsuit With Estate Of Henrietta Lacks
24 Feb 2026 //
FIERCE PHARMA
Novartis Reveals Rhapsido`s Broader Reach Beyond CSU at AAAAI
23 Feb 2026 //
GLOBENEWSWIRE
Novartis to Exit India unit in $159M deal; Share Surge
21 Feb 2026 //
REUTERS
Novartis` Remibrutinib First to Meet Phase III Endpoint in CIndU
20 Feb 2026 //
GLOBENEWSWIRE
Novartis Finds Natural Partnership In Macrocycle Biotech
20 Feb 2026 //
FIERCE BIOTECH
Novartis Jettisons Ph. 1 Cancer Candidate After 0% Efficacy
19 Feb 2026 //
FIERCE BIOTECH
Trump meets Novartis CEO, says Drugmaker Building 11 US plants
19 Feb 2026 //
REUTERS
Novartis Vanrafia Shows Phase III Data Backing Kidney Function
13 Feb 2026 //
GLOBENEWSWIRE
Niowave, Novartis Ink Actinium-225 Deal for Cancer Therapy
11 Feb 2026 //
PR NEWSWIRE
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
Novartis CEO Pay Soars 30% To $32M In 2025
09 Feb 2026 //
FIERCE PHARMA
